U.S. Markets closed
  • S&P Futures

    3,266.75
    -8.25 (-0.25%)
     
  • Dow Futures

    26,993.00
    -62.00 (-0.23%)
     
  • Nasdaq Futures

    10,951.75
    -37.25 (-0.34%)
     
  • Russell 2000 Futures

    1,478.20
    -4.60 (-0.31%)
     
  • Crude Oil

    39.57
    +0.26 (+0.66%)
     
  • Gold

    1,913.50
    +2.90 (+0.15%)
     
  • Silver

    24.70
    +0.31 (+1.28%)
     
  • EUR/USD

    1.1766
    -0.0007 (-0.0588%)
     
  • 10-Yr Bond

    0.6710
    -0.0230 (-3.31%)
     
  • Vix

    27.78
    +1.95 (+7.55%)
     
  • GBP/USD

    1.2815
    -0.0003 (-0.0205%)
     
  • BTC-USD

    10,460.45
    +22.73 (+0.22%)
     
  • CMC Crypto 200

    221.93
    -13.65 (-5.80%)
     
  • FTSE 100

    5,804.29
    -202.76 (-3.38%)
     
  • Nikkei 225

    23,360.30
    +40.90 (+0.18%)
     

Electromed, Inc. to Participate in the 2020 Colliers Institutional Investor Conference

Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2020 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 10, 2020.

About Electromed, Inc.

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200826005713/en/

Contacts

Electromed, Inc.
Mike MacCourt, Chief Financial Officer
(952) 758-9299
mmaccourt@electromed.com

The Equity Group Inc.
Kalle Ahl, CFA
(212) 836-9614
kahl@equityny.com

Devin Sullivan
(212) 836-9608
dsullivan@equityny.com